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treated with healthy subjects MPs did not affect  ow-induced 
dilation, these vessels showed a reduced prostacyclin-component 
that was completely compensated by the NO-component of the 
response. The endothelial dysfunction induced by MPs from OSAS 
was caused by the reduction of both NO- and prostacyclin- but 
not the endothelium-derived hyperpolarizing factor-components of 
the response in SMA. These data provide evidence that circulating 
MPs from OSAS patients in uence both endothelial function and 
vascular reactivity.
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During cell activation or apoptosis, cells release vesicles, also 
called microparticles (MPs) from the plasma membrane. Since 
composition of MPs is dependent on cell origin and the type of 
stimulation, we compared the effects of MPs generated from both 
apoptotic T lymphocytes and apoptotic monocytes on endothelial 
function with respect to both nitric oxide (NO) pathway and 
reactive oxygen species (ROS). MPs were produced by treatment of 
either human T lymphocytes with the apoptotic agent actinomycin 
D or human monocytic cell line THP-1 with the apoptotic agent, 
the etoposide VP-16. Human Eahy 926 endothelial cells were 
incubated with 10 g/ml MPs for 24h. Apoptotic MPs from human 
T lymphocytes decreased NO production that was associated 
with overexpression and phosphorylation of endothelial NO-
synthase (eNOS). Also, T lymphocytes MPs enhanced expression 
of caveolin-1 and decreased its phosphorylation. T lymphocytes 
MPs enhanced ROS by a mechanism sensitive to xanthine oxidase 
and P-IkappaBalpha inhibitors. PI3-kinase inhibition reduced the 
effects of T lymphocytes MPs on eNOS, but not on caveolin-1, 
whereas it enhanced the effects of MPs on ROS production. 
Inhibition of MEK reversed eNOS phosphorylation but it had 
no effect on ROS production induced by T lymphocytes MPs. 
By contrast, apoptotic MPs from human monocytes increased 
both NO production and in much less extent ROS. These effects 
were associated with a decrease of caveolin-1 expression and 
increased its phosphorylation, without affecting eNOS expression 
and phosphorylation. The inhibitor of the PI-3kinase, LY294002, 
reversed the effects of monocyte MPs on caveolin-1 expression 
but not on its phosphorylation. The MEK1/2 inhibitor, U0126, 
reversed the decrease of caveolin-1 expression induced by MPs 
from monocytes. Interestingly, U0126 potentiated ROS production 
induced by monocyte MPs. Whereas in vivo injection of T 
lymphocytes MPs in mice impaired endothelial function, apoptotic 
MPs from human monocytes did not affect endothelium-dependent 
relaxation. In addition, monocyte MPs were able to promote in 
vitro angiogenesis. In summary, these results highlight differential 
effects of apoptotic MPs from different origins by activating 
diverse multiple pathways related to NO and ROS productions.
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Telomerase, a ribonucleoprotein enzyme, catalyses the synthesis 
of repeated telomeric sequences. Telomeres are required for 
chromosome stability and cell viability and a decrease of their 
length was found to be associated with several cardiovascular 
diseases. Telomerase contains the hTR RNA, and several proteins, 
including the reverse transcriptase hTERT. The hTR 5’ domain 
contains the template sequence for DNA synthesis and binds hTERT. 
The H/ACA 3’ domain is required for stability and associates with 
4 proteins (Dyskerin, GAR1, NOP10 and NHP2 proteins). Limited 
information is available on telomerase assembly. A pre-complex 
containing Dyskerine, NOP10, NHP2 and an assembly factor, called 
NAF1, is likely formed in the cytoplasm and transported to the 
nucleus, where it associates with the H/ACA domain of nascent 
RNA. Exchange of NAF1 for GAR1 allows the production of the 
functional H/ACA RNP domain. We showed that several factors 
are implicated in H/ACA RNP assembly : NUFIP, the R2TP complex, 
and HSP90. The SMN complex, containing the SMN, Gemin2 to 
Gemin8 and Unrip proteins may also be involved, since protein SMN 
interacts with GAR1.
For further analysis on the role of the SMN complex in telomerase 
assembly, we tested by yeast two hybrid assays whether other 
proteins of this complex can interact with H/ACA RNP proteins 
and their assembly factors. We discovered a possible interaction 
between NAF1, Gemin 3 and Gemin8. Hence, the SMN complex may 
be involved in the replacement of NAF1 by GAR1 : it may associate 
with GAR1 through an interaction with SMN, and with the pre-H/
ACA RNP complex through interaction of NAF1 with Gemin3 and 
8, allowing the replacement of NAF1 by GAR1. We are testing this 
hypothesis. The SMN complex may also be involved in hTERT binding 
to the 5’ domain of hTR and we will also explore this possibility.
Through these studies we should bring insight into telomerase 
assembly that may be useful to understand telomere attrition in 
cardiovascular diseases.
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Contexte — Les MP sont générées par le remaniement de la 
membrane plasmique suite à l’activation des cellules sanguines ou 
des cellules endothéliales.
Objectif — Nous avons caractérisé les microparticules circulantes 
chez les patients atteints du syndrome des anticorps anti-
phospholipides (SAPL), thrombophilie acquise caractérisée par un 
risque augmenté de thromboses et de complications obstétricales. 
